Literature DB >> 11559028

Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors.

A S Kalgutkar1, D K Dalvie, N Castagnoli, T J Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11559028     DOI： 10.1021/tx010073b

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN： 0893-228X            Impact factor:   3.739


× No keyword cloud information.
  24 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

2.  A systematic review and meta-analysis examining the interrelationships between chemical and non-chemical stressors and inherent characteristics in children with ADHD.

Authors:  Frances M Nilsen; Nicolle S Tulve
Journal:  Environ Res       Date:  2019-11-01       Impact factor: 6.498

3.  The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes.

Authors:  B Drukarch; J Flier; C A M Jongenelen; G Andringa; A N M Schoffelmeer
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 4.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

5.  Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.

Authors:  Rati K P Tripathi; Vishnu M Sasi; Sukesh K Gupta; Sairam Krishnamurthy; Senthil R Ayyannan
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

6.  Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase.

Authors:  Saqlain Haider; Manal Alhusban; Narayan D Chaurasiya; Babu L Tekwani; Amar G Chittiboyina; Ikhlas A Khan
Journal:  Future Med Chem       Date:  2018-05-23       Impact factor: 3.808

7.  Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.

Authors:  Tomáš Páleníček; Michaela Fujáková; Martin Brunovský; Jiří Horáček; Ingmar Gorman; Marie Balíková; Lukáš Rambousek; Kamila Syslová; Petr Kačer; Petr Zach; Věra Bubeníková-Valešová; Filip Tylš; Anna Kubešová; Jana Puskarčíková; Cyril Höschl
Journal:  Psychopharmacology (Berl)       Date:  2012-07-29       Impact factor: 4.530

8.  Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.

Authors:  R R Ramsay; C Dunford; P K Gillman
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

9.  Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals.

Authors:  Walter Rangel Lopes de Campos; Dayaneethie Coopusamy; Lynn Morris; Bongani M Mayosi; Makobetsa Khati
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

Review 10.  Current place of monoamine oxidase inhibitors in the treatment of depression.

Authors:  Kenneth I Shulman; Nathan Herrmann; Scott E Walker
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.